The thymus in GVHD pathophysiology.

The thymus in GVHD pathophysiology.

A favorable outcome of allogeneic hematopoietic stem-cell transplantation (HSCT) depends on the complete reconstitution of the host's immune system. While recovery of peripheral T cells occurs in transplant recipients via both thymus-dependent and thymus-independent pathways, the regeneration o...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Krenger, W, Holländer, G
Natura:	Journal article
Lingua:	English
Pubblicazione:	2008

Documenti analoghi

The immunopathology of thymic GVHD.
di: Krenger, W, et al.
Pubblicazione: (2008)

Epithelial cytoprotection sustains ectopic expression of tissue-restricted antigens in the thymus during murine acute GVHD.
di: Dertschnig, S, et al.
Pubblicazione: (2013)

The role of the thymus in allogeneic haematopoietic stem cell transplantation
di: Krenger, W, et al.
Pubblicazione: (2010)

The role of the thymus in allogeneic hematopoietic stem cell transplantation.
di: Krenger, W, et al.
Pubblicazione: (2010)

Milestones in acute GVHD pathophysiology
di: Gerard Socie, et al.
Pubblicazione: (2022-12-01)

A short primer on early molecular and cellular events in thymus organogenesis and replacement.
di: Barthlott, T, et al.
Pubblicazione: (2007)

Impact of oral microbiota on pathophysiology of GVHD
di: Akira Yamamoto, et al.
Pubblicazione: (2023-03-01)

The role of the thymus in allogeneic haematopoietic stem cell transplantation
di: Krenger, W, et al.
Pubblicazione: (2010)

GVHD TREATMENT
di: Elif BirtaşAteşoğlu
Pubblicazione: (2021-11-01)

Stabilized beta-catenin in thymic epithelial cells blocks thymus development and function.
di: Zuklys, S, et al.
Pubblicazione: (2009)

GVHD Prophylaxis 2020
di: Mahasweta Gooptu, et al.
Pubblicazione: (2021-04-01)

Emerging strategies to boost thymic function.
di: Holländer, G, et al.
Pubblicazione: (2010)

Thymic T-cell development in allogeneic stem cell transplantation.
di: Krenger, W, et al.
Pubblicazione: (2011)

Regulatory T Cells in GVHD Therapy
di: Wen-wen Guo, et al.
Pubblicazione: (2021-06-01)

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
di: Najla El Jurdi, et al.
Pubblicazione: (2021-05-01)

Late onset of oral chronic GVHD
di: Paulo Sérgio da Silva Santos, et al.
Pubblicazione: (2008-06-01)

Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD
di: Jonathan L. Golob, et al.
Pubblicazione: (2019-10-01)

Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model
di: Shinri Sato, et al.
Pubblicazione: (2025-01-01)

Steroid-Refractory Acute GVHD: Predictors and Outcomes
di: Jason R. Westin, et al.
Pubblicazione: (2011-01-01)

ER stress: an emerging regulator in GVHD development
di: Hee-Jin Choi, et al.
Pubblicazione: (2023-09-01)

Rearrangement of T Cell genome architecture regulates GVHD
di: Yaping Sun, et al.
Pubblicazione: (2022-09-01)

The Role of Bacteria and Pattern Recognition Receptors in GvHD
di: E. Holler, et al.
Pubblicazione: (2010-01-01)

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
di: Shabnam Shokouhi, et al.
Pubblicazione: (2015-09-01)

REDUCED INCIDENCE OF GVHD IN RECIPIENTS OF T-CELL DEPLETED MARROW
di: Apperley, J, et al.
Pubblicazione: (1986)

A short primer on early molecular and cellular events in thymus organogenesis and replacement
di: T Barthlott, et al.
Pubblicazione: (2006-06-01)

Soluble lymphotoxin is an important effector molecule in GVHD and GVL.
di: Markey, K, et al.
Pubblicazione: (2010)

Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model
di: Shinri Sato, et al.
Pubblicazione: (2025-02-01)

The Global Thymus Network: past, present and future.
di: Takahama, Y, et al.
Pubblicazione: (2009)

Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD
di: Attilio Olivieri, et al.
Pubblicazione: (2024-09-01)

Separation of GVL from GVHD -location, location, location
di: Takanori Teshima, et al.
Pubblicazione: (2023-12-01)

Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
di: Takahide Ara, et al.
Pubblicazione: (2021-08-01)

Roles of the intestinal microbiota and microbial metabolites in acute GVHD
di: Dandan Lin, et al.
Pubblicazione: (2021-10-01)

Loss of thymus epithelial cell identity following the constitutive activation of the canonical Wnt pathway
di: Zuklys, S, et al.
Pubblicazione: (2007)

The significance of M1‐polarized CD163+ macrophages in acute graft‐versus‐host disease (GVHD): Possible mechanisms of GVHD in the development of skin lesions
di: Yusuke Muto, et al.
Pubblicazione: (2023-08-01)

Pathologies of the thymus
di: A Van Steen, et al.
Pubblicazione: (2013-09-01)

Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD
di: Irina Kostareva, et al.
Pubblicazione: (2022-09-01)

Controversies and expectations for the prevention of GVHD: A biological and clinical perspective
di: Benjamin Watkins, et al.
Pubblicazione: (2022-11-01)

GVHD treatment with extracorporeal photopheresis in Brazil: a national survey
di: Giancarlo Fatobene, et al.
Pubblicazione: (2022-07-01)

Progress of cGVHD pathogenesis from the perspective of B cells
di: Xiaoping Li, et al.
Pubblicazione: (2019-08-01)

Clearing the AIRE: on the pathophysiological basis of the autoimmune polyendocrinopathy syndrome type-1.
di: Shikama, N, et al.
Pubblicazione: (2009)